Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenylate kinase 3 pseudogene 4 (AK3P4) is a pseudogene mapped in humans. As a pseudogene, AK3P4 does not code for a functional protein and is considered a non-target from a therapeutic or drug development perspective. It is an unprocessed pseudogene related to the functional gene AK3, which encodes an enzyme (adenylate kinase 3) involved in nucleotide metabolism, but AK3P4 itself does not produce a protein product[3][5]. Current databases list no biological functions, disease associations, interacting drugs, or known utility as a biomarker for AK3P4. There is no evidence supporting a role as a therapeutic target, nor are there therapeutic challenges or safety concerns associated with this pseudogene[5]. AK3P4 is distinct from the functional AK3 gene, which encodes a mitochondrial enzyme with a role in nucleotide metabolism, but AK3P4 itself has no known protein product or biological activity in humans. This information is consistent with multiple gene and protein databases[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenylate kinase 3 pseudogene 4 (AK3P4).